medroxyprogesterone acetate has been researched along with Nephrolithiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cochrane, BB; Howard, BV; Maalouf, NM; Robbins, JA; Sakhaee, K; Sato, AH; Welch, BJ | 1 |
| Assimos, D | 1 |
1 trial(s) available for medroxyprogesterone acetate and Nephrolithiasis
| Article | Year |
|---|---|
Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials.
Topics: Aged; Clinical Trials as Topic; Confidence Intervals; Drug Combinations; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Incidence; Medroxyprogesterone Acetate; Middle Aged; Nephrolithiasis; Odds Ratio; Postmenopause; Risk Assessment; Risk Factors; United States | 2010 |
1 other study(ies) available for medroxyprogesterone acetate and Nephrolithiasis
| Article | Year |
|---|---|
Re.: Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative Hormone Therapy Trials.
Topics: Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Medroxyprogesterone Acetate; Nephrolithiasis; Postmenopause | 2011 |